Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;33(1):42-6.
doi: 10.5114/pdia.2015.48039. Epub 2016 Feb 29.

Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid

Affiliations

Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid

Aleksandra Iljin et al. Postepy Dermatol Alergol. 2016 Feb.

Abstract

Introduction: Basal cell carcinoma (BCC) is the most common malignant neoplasm of the eyelids and surrounding structures, usually developing in the area of the lower lid and medial canthus. Invasive forms of BCC are connected with a high risk of recurrence, often due to incomplete excision of these lesions.

Aim: Clinical and pathological analysis of recurrent BCCs of the eyelids and surrounding structures.

Material and methods: We present clinical and pathological analysis including immunohistochemical reaction to Ki-67 antigen of 19 patients (11 women, 8 men) operated for recurrent BCCs of the eyelids in 2000-2012.

Results: In most cases, recurrences were present on the lower lid and in the medial canthus. In 15 patients the histopathological type did not change and in 4 cases it transformed into more invasive forms. The values of Ki-67 index for primary BCCs ranged between 1% and 20%, and for relapsing lesions between 11% and 48%.

Conclusions: Proper clinical and pathological evaluation to determine the risk of relapse in BCCs of the eyelids and surrounding structures should include the analysis of prognostic factors, in particular location and size, histopathological type and radicalness of surgical treatment of primary BCCs. Clinical and pathological analysis of patients with recurrent BCC of the eyelids and surrounding structures should be combined with the evaluation of proliferation index Ki-67, which is essential for prognosis and choice of the appropriate therapeutic method.

Keywords: Ki-67 antigen; eyelid; recurrent BCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A – Primary focus of BCC within medial canthus. B – Recurrence of the tumor after 3 years from excision. C – Status after recurrent tumor excision and reconstruction with the use of the glabellar flap

Similar articles

Cited by

References

    1. Coroi M, Rosca E, Mutiu G, et al. Eyelid tumors: histopathological study performed in County Hospital of Oradea between 2000-2007. Rom J Morphol Embryol. 2010;51:111–5. - PubMed
    1. Zieliński T, Pisera P, Siewiera I, et al. Chirurgiczne leczenie złośliwych nowotworów powiek. Pol Merk Lek. 2013;34:214–8. - PubMed
    1. Zieliński T, Iljin A, Antoszewski B. Nowotwory złośliwe powiek – wyniki leczenia chirurgicznego i wybór metody rekonstrukcji. Nowotwory J Oncol. 2012;62:431–7.
    1. Cook BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies. Ophthalmology. 2001;108:2089–98. - PubMed
    1. Donaldson MJ, Sullivan TJ, Whitehead KJ, et al. Squamous cell carcinoma of the eyelids. Br J Ophthalmol. 2002;86:1161–5. - PMC - PubMed

LinkOut - more resources